Literature DB >> 16389638

Lentiviral gene delivery to CNS by spinal intrathecal administration to neonatal mice.

Elena Fedorova1, Lorenzo Battini, Ainu Prakash-Cheng, Daniele Marras, G Luca Gusella.   

Abstract

BACKGROUND: Direct injection of lentivectors into the central nervous system (CNS) mostly results in localized parenchymal transgene expression. Intrathecal gene delivery into the spinal canal may produce a wider dissemination of the transgene and allow diffusion of secreted transgenic proteins throughout the cerebrospinal fluid (CSF). Herein, we analyze the distribution and expression of LacZ and SEAP transgenes following the intrathecal delivery of lentivectors into the spinal canal.
METHODS: Four weeks after intrathecal injection into the spinal canal of newborn mice, the expression of the LacZ gene was assessed by histochemical staining and by in situ polymer chain reaction (PCR). Following the spinal infusion of a lentivector carrying the SEAP gene, levels of enzymatically active SEAP were measured in the CSF, blood serum, and in brain extracts.
RESULTS: Intrathecal spinal canal delivery of lentivectors to newborn mice resulted in patchy, widely scattered areas of beta-gal expression mostly in the meninges. The transduction of the meningeal cells was confirmed by in situ PCR. Following the spinal infusion of a lentivector carrying the SEAP gene, sustained presence of the reporter protein was detected in the CSF, as well as in blood serum, and brain extracts.
CONCLUSIONS: These findings indicate that intrathecal injections of lentivectors can provide significant levels of transgene expression in the meninges. Unlike intracerebral injections of lentivectors, intrathecal gene delivery through the spinal canal appears to produce a wider diffusion of the transgene. This approach is less invasive and may be useful to address those neurological diseases that benefit from the ectopic expression of soluble factors impermeable to the blood-brain barrier. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16389638     DOI: 10.1002/jgm.861

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  10 in total

1.  Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons.

Authors:  Sandra Duque; Béatrice Joussemet; Christel Riviere; Thibaut Marais; Laurence Dubreil; Anne-Marie Douar; John Fyfe; Philippe Moullier; Marie-Anne Colle; Martine Barkats
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

2.  The Joubert syndrome protein ARL13B binds tubulin to maintain uniform distribution of proteins along the ciliary membrane.

Authors:  Ekaterina Revenkova; Qing Liu; G Luca Gusella; Carlo Iomini
Journal:  J Cell Sci       Date:  2018-05-04       Impact factor: 5.285

3.  Lentiviral-mediated gene transfer to the sheep brain: implications for gene therapy in Batten disease.

Authors:  Kathryn S Linterman; David N Palmer; Graham W Kay; Lucy A Barry; Nadia L Mitchell; Robin G McFarlane; Michael A Black; Mark S Sands; Stephanie M Hughes
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

4.  Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts.

Authors:  Silvia Smaldone; Jacopo Olivieri; Gabriele Luca Gusella; Gianluca Moroncini; Armando Gabrielli; Francesco Ramirez
Journal:  Fibrogenesis Tissue Repair       Date:  2011-03-01

5.  Loss of polycystin-1 causes centrosome amplification and genomic instability.

Authors:  Lorenzo Battini; Salvador Macip; Elena Fedorova; Steven Dikman; Stefan Somlo; Cristina Montagna; G Luca Gusella
Journal:  Hum Mol Genet       Date:  2008-06-19       Impact factor: 6.150

6.  Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy.

Authors:  Stefania Corti; Monica Nizzardo; Martina Nardini; Chiara Donadoni; Sabrina Salani; Dario Ronchi; Francesca Saladino; Andreina Bordoni; Francesco Fortunato; Roberto Del Bo; Dimitra Papadimitriou; Federica Locatelli; Giorgia Menozzi; Sandra Strazzer; Nereo Bresolin; Giacomo P Comi
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

7.  Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteins.

Authors:  Travis S Hughes; Stephen J Langer; Kirk W Johnson; Raymond A Chavez; Linda R Watkins; Erin D Milligan; Leslie A Leinwand
Journal:  Mol Ther       Date:  2008-10-21       Impact factor: 11.454

8.  Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy.

Authors:  Alexia Kagiava; Irene Sargiannidou; George Theophilidis; Christos Karaiskos; Jan Richter; Stavros Bashiardes; Natasa Schiza; Marianna Nearchou; Christina Christodoulou; Steven S Scherer; Kleopas A Kleopa
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

9.  Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons.

Authors:  Raphael Rozenfeld; Ittai Bushlin; Ivone Gomes; Nikos Tzavaras; Achla Gupta; Susana Neves; Lorenzo Battini; G Luca Gusella; Alexander Lachmann; Avi Ma'ayan; Robert D Blitzer; Lakshmi A Devi
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

10.  Elongator subunit 3 (ELP3) modifies ALS through tRNA modification.

Authors:  Andre Bento-Abreu; Gunilla Jager; Bart Swinnen; Laura Rué; Stijn Hendrickx; Ashley Jones; Kim A Staats; Ines Taes; Caroline Eykens; Annelies Nonneman; Rik Nuyts; Mieke Timmers; Lara Silva; Alain Chariot; Laurent Nguyen; John Ravits; Robin Lemmens; Deirdre Cabooter; Ludo Van Den Bosch; Philip Van Damme; Ammar Al-Chalabi; Anders Bystrom; Wim Robberecht
Journal:  Hum Mol Genet       Date:  2018-04-01       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.